BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1281 related articles for article (PubMed ID: 28549917)

  • 1. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
    Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
    Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.
    Liu Z; Lu Z; Jing R; Zuo B; Gao X; Han G; Qi H; Wu L; Liu Y; Yin H
    Theranostics; 2019; 9(14):4006-4018. PubMed ID: 31281528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.
    Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX
    Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses.
    Zuo B; Zhang Y; Zhao K; Wu L; Qi H; Yang R; Gao X; Geng M; Wu Y; Jing R; Zhou Q; Seow Y; Yin H
    J Hematol Oncol; 2022 Apr; 15(1):46. PubMed ID: 35488312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
    Pang XH; Chen MS; Jia WH; Zhou XX
    Ai Zheng; 2008 Dec; 27(12):1233-8. PubMed ID: 19079985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
    Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
    J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma.
    Wang Q; Luan W; Warren L; Kadri H; Kim KW; Goz V; Blank S; Isabel Fiel M; Hiotis SP
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):574-582. PubMed ID: 26786094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
    Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice.
    Cany J; Barteau B; Tran L; Gauttier V; Archambeaud I; Couty JP; Turlin B; Pitard B; Vassaux G; Ferry N; Conchon S
    J Hepatol; 2011 Jan; 54(1):115-21. PubMed ID: 20961645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma.
    Zhong X; Zhou Y; Cao Y; Ding J; Wang P; Luo Y; Liu H; Zhu Z; Jing X
    Int J Hyperthermia; 2020; 37(1):1210-1218. PubMed ID: 33100037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
    Hong Y; Peng Y; Guo ZS; Guevara-Patino J; Pang J; Butterfield LH; Mivechi NF; Munn DH; Bartlett DL; He Y
    Hepatology; 2014 Apr; 59(4):1448-58. PubMed ID: 24122861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice.
    Grimm CF; Ortmann D; Mohr L; Michalak S; Krohne TU; Meckel S; Eisele S; Encke J; Blum HE; Geissler M
    Gastroenterology; 2000 Oct; 119(4):1104-12. PubMed ID: 11040197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
    Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
    J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Oncology; 2004; 66(4):323-30. PubMed ID: 15218301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor.
    Wang C; Huang X; Wu Y; Wang J; Li F; Guo G
    Int J Biol Sci; 2020; 16(4):633-643. PubMed ID: 32025211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.